BF.B
46
-7
O
39
2
LLY
62
3
VZ
50
-2
FE
46
-11
MO
69
-2
DRI
66
3
MRK
30
-3
D
38
-3
WHR
42
2
MSFT
48
2
CHRW
50
-3
CAT
40
-2
NTRS
47
2
ZBH
54
-3
M
25
4
K
59
2
NWL
35
3
PNC
52
3
HES
61
2
BF.B
46
-7
O
39
2
LLY
62
3
VZ
50
-2
FE
46
-11
MO
69
-2
DRI
66
3
MRK
30
-3
D
38
-3
WHR
42
2
MSFT
48
2
CHRW
50
-3
CAT
40
-2
NTRS
47
2
ZBH
54
-3
M
25
4
K
59
2
NWL
35
3
PNC
52
3
HES
61
2
Financhill
Back

John Hancock Financial Opportunities Fund Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
40

BTO
John Hancock Financial Opportunities Fund

Last Price:
$31.90
Seasonality Move:
2.47%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$97.66
Seasonality Move:
6.73%
Sell
40
John Hancock Financial Opportunities Fund (BTO) is a Sell

Is John Hancock Financial Opportunities Fund a Buy, Sell or Hold?

  • The current John Hancock Financial Opportunities Fund [BTO] share price is $32.91. The Score for BTO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BTO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BTO Stock Price Chart

What is John Hancock Financial Opportunities Fund's stock price today?

  • The John Hancock Financial Opportunities Fund share price today is $32.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTO is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

BTO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1 Sell
Relative Strength Index (14 RSI): 27.55 Sell
Chaikin Money Flow: -6490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.34 - 37.78) Sell
Bollinger Bands (100): (34.47 - 38.11) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

BTO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34 Sell
20-day SMA: 35.6 Sell
50-day SMA: 36.06 Sell
200-day SMA: 33.43 Sell
8-day EMA: 33.85 Sell
20-day EMA: 35.06 Sell
50-day EMA: 35.85 Sell
200-day EMA: 34.02 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

John Hancock Financial Opportunities Fund Earnings Growth & BTO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

John Hancock Financial Opportunities Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):